Tramadol hydrochloride + Paracetamol
Doreta is a combination medicine containing two painkillers: tramadol and paracetamol, which together relieve pain.
Doreta is indicated for the treatment of moderate to severe pain, if the doctor considers it necessary to administer tramadol in combination with paracetamol.
Doreta is intended for use in adults and adolescents over 12 years of age.
Before starting to take Doreta, the patient should discuss the following with their doctor:
Tolerance, dependence and addiction
This medicine contains tramadol, which is an opioid. Repeated use of opioids can lead to the medicine becoming less effective (the patient gets used to the medicine, which is called tolerance). Repeated use of Doreta can also lead to the development of dependence, abuse and addiction, which can result in life-threatening overdose. The risk of these side effects may increase with the dose and duration of use.
Dependence can make it difficult for the patient to control the dose of the medicine or how often it is taken.
The risk of dependence is different for different people. The risk of dependence on Doreta may be higher if:
If any of the following symptoms occur while taking Doreta, it may indicate dependence:
If any of these symptoms occur, the patient should talk to their doctor to discuss the best course of treatment, including when to stop the medicine and how to do it safely (see section 3 "Stopping Doreta").
Respiratory depression during sleep
Doreta contains an active substance belonging to the opioid group. Opioids can cause respiratory depression during sleep, such as central sleep apnea (shallow/broken breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood).
The risk of central sleep apnea depends on the opioid dose. The doctor may consider reducing the total opioid dose if the patient has developed central sleep apnea.
After taking tramadol in combination with certain antidepressants or tramadol alone, there is a small risk of developing a condition called serotonin syndrome. If the patient experiences any symptoms of this serious condition, they should seek medical attention immediately (see section 4 "Possible side effects").
Tramadol is converted in the liver by an enzyme. In some people, there is a certain variation of this enzyme, which can have different effects. In some people, pain relief may not be sufficient, and in others, it is more likely to develop severe side effects.
The patient should stop taking the medicine and contact their doctor immediately if they experience any of the following side effects: slow breathing or shallow breathing, confusion, drowsiness, pinpoint pupils, nausea or vomiting, constipation, loss of appetite.
If any of the above situations have occurred to the patient in the past or have occurred while taking Doreta, they should inform their doctor. The doctor will decide whether to continue taking the medicine.
Use in children with respiratory disorders
Tramadol is not recommended for use in children with respiratory disorders, as the symptoms of tramadol toxicity may be exacerbated in them.
The patient should talk to their doctor if they experience any of the following symptoms while taking Doreta: excessive tiredness, loss of appetite, severe abdominal pain, nausea, vomiting or low blood pressure. This may indicate that the patient has adrenal insufficiency (low cortisol levels). If such symptoms occur, the patient should contact their doctor, who will decide whether the patient needs hormone replacement therapy.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Taking Doreta with monoamine oxidase inhibitors (MAOIs) is contraindicated(see section "When not to take Doreta").
It is not recommended to take Doreta with the following medicines:
The patient should inform their doctor or pharmacist if they are taking:
The risk of side effects increases if the patient is taking:
triptans (medicines used to treat migraines) or selective serotonin reuptake inhibitors (SSRIs) (used to treat depression). If the patient experiences confusion, agitation, fever, sweating, uncoordinated movement of limbs or eyes, involuntary muscle contractions or diarrhea, they should contact their doctor.
other painkillers like morphine and codeine (also used to treat cough),
baclofen (a muscle relaxant), blood pressure lowering medicines or antihistamines.
The patient should contact their doctor if they experience drowsiness or fainting.
Taking Doreta with sedatives, such as benzodiazepines or similar medicines, increases the risk of drowsiness, breathing difficulties (respiratory depression), coma and can be life-threatening. Therefore, concurrent use should only be considered if other treatment options are not possible. If the doctor has prescribed Doreta with sedatives, the doctor should limit the dose and duration of concurrent treatment. The patient should inform their doctor about all sedatives they are taking and strictly follow the doctor's dosage recommendations. It may be helpful to inform friends or relatives to be aware of the above symptoms. If such symptoms occur, the patient should contact their doctor.
medicines that can cause seizures (fits), such as certain antidepressants or antipsychotics. The risk of seizures may increase if the patient takes Doreta with these medicines. The doctor will advise whether Doreta is suitable for the patient.
certain antidepressants. Doreta may interact with these medicines and cause serotonin syndrome (see section 4 "Possible side effects").
warfarin or phenprocoumon (medicines used to thin the blood). The effect of these medicines may change, and bleeding may occur. If the patient experiences any prolonged or unexpected bleeding, they should contact their doctor immediately.
gabapentin or pregabalin for the treatment of epilepsy or neuropathic pain (nerve pain).
The effect of Doreta may change if it is taken with:
metoclopramide, domperidone or ondansetron (medicines used to treat nausea and vomiting),
cholestyramine (a medicine used to lower cholesterol levels in the blood).
The doctor will decide which medicines can be safely taken with Doreta.
Doreta may cause drowsiness. Alcohol increases the feeling of drowsiness. The patient should not drink alcohol while taking Doreta.
If the patient is pregnant or breastfeeding, thinks they may be pregnant or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Breastfeeding
Tramadol is excreted into breast milk. Therefore, Doreta should not be taken more than once while breastfeeding, or if Doreta is taken more than once, breastfeeding should be stopped.
Fertility
Based on the use of tramadol in humans, it is suggested that tramadol does not affect fertility in women and men. There is no available data on the effect of combined tramadol and paracetamol treatment on fertility.
The patient should consult their doctor or pharmacist before taking any medicine.
Doreta may cause drowsiness, which can affect the ability to drive and use machines.
If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
This medicine should always be taken as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.
Before starting treatment and regularly during treatment, the doctor will discuss with the patient what to expect from Doreta, when and for how long to take it, when to contact the doctor and when to stop taking it (see also section 2).
Doreta should be taken for the shortest possible time.
The medicine should not be taken in children under 12 years of age.
The dose should be adjusted according to the severity of the pain and the individual response of the patient to treatment.
The patient should take the smallest effective dose that relieves the pain.
If the doctor has not recommended otherwise, the recommended dose of Doreta is 2 tablets for adults and adolescents over 12 years of age.
If necessary, the doctor may recommend taking additional doses. Additional doses should not be taken more frequently than every 6 hours.
Do not take Doreta more frequently than recommended by the doctor.
In patients over 75 years of age, the elimination of tramadol from the body may be delayed. In these patients, the doctor may recommend prolonging the time interval between doses.
Doreta should not be taken in case of severe liver or kidney impairment.
In case of mild or moderate impairment, the doctor may recommend prolonging the time interval between doses.
The tablet for oral suspension should be dissolved in a glass of drinking water, stirred with a spoon and the resulting suspension taken, or the tablet can be swallowed whole, washed down with a sufficient amount of liquid.
If the patient feels that the effect of Doreta is too strong (i.e., drowsiness or breathing problems occur) or too weak (i.e., insufficient pain relief), they should consult their doctor.
In case of taking a higher dose of Doreta than recommended, even if the patient feels well, they should immediately consult their doctor or pharmacist. There is a risk of liver damage, the symptoms of which may appear later.
If a dose of Doreta is missed, the pain may return. The patient should not take a double dose to make up for the missed dose, but should continue taking the medicine according to the established schedule.
The patient should not suddenly stop taking Doreta without their doctor's advice. If the patient wants to stop taking the medicine, they should discuss it with their doctor, especially if they have been taking it for a long time.
The doctor will advise when and how to stop taking Doreta; this may involve gradually reducing the dose to minimize the risk of side effects (withdrawal symptoms).
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Doreta can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (frequency cannot be estimated from the available data):
The following side effects have been reported by patients taking medicines containing only tramadol or paracetamol. However, if any of these side effects occur while taking Doreta, the patient should inform their doctor:
Rarely, patients taking tramadol for a period of time may experience malaise when the medicine is stopped abruptly.
Patients may feel anxious, restless, nervous or agitated, overactive, insomnia or gastrointestinal disorders. In a very small number of patients, panic attacks, hallucinations, unusual sensations such as itching, tingling, numbness of the skin and ringing in the ears may occur. If any of these symptoms or any other unusual symptoms occur, the patient should consult their doctor or pharmacist as soon as possible.
Frequency not known: hiccups
Serotonin syndrome, the symptoms of which may include changes in mental status (e.g., agitation, hallucinations, coma), as well as other symptoms, such as fever, rapid heart rate, unstable blood pressure, involuntary muscle contractions, muscle stiffness, lack of coordination and (or) gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) (see section 2 "Important information before taking Doreta").
In rare cases, blood tests may show certain disorders, such as a low platelet count, which can cause nosebleeds or bleeding gums.
Very rarely, cases of severe skin reactions have been reported after taking medicines containing paracetamol.
Rarely, cases of respiratory depression have been reported after taking medicines containing tramadol.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The medicine should be stored in a safe place, inaccessible to others. It can cause serious harm and be fatal to people it has not been prescribed for.
Do not take this medicine after the expiry date stated on the blister pack and carton after: EXP.
The expiry date refers to the last day of the month stated.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White or almost white, round, biconvex tablets. Tablet size: approximately 13 mm.
Doreta is available in packs containing 10, 30 tablets for oral suspension in blisters in a cardboard box.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
To obtain more detailed information on this medicine, the patient should contact their local representative of the marketing authorization holder:
Krka - Polska Sp. z o.o.
Równoległa 5
02-235 Warsaw
phone: +48 22 573 75 00
Poland, Slovakia, Slovenia, Hungary | Doreta |
Portugal | Tramadol + Paracetamol Krka |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.